For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240711:nRSK9425Va&default-theme=true
RNS Number : 9425V Tavistock Investments PLC 11 July 2024
11 July 2024
Tavistock Investments Plc
("Tavistock" or the "Company")
Follow up to Titan termination announcement
Tavistock confirms the accuracy of the announcement that it made to the market
on 8 July 2024. The table below demonstrates the unacceptable performance by
Titan.
Performance 27(th) Aug 22 - 4(th) Jan 24
Performance vs Benchmark Quartile Rank Fund Rank Percentile Rank
ACUMEN Portfolio 4 -7.89% 4(th) 176/177 100(th)
ACUMEN Portfolio 5 -8.27% 4(th) 177/177 100(th)
ACUMEN Portfolio 6 -9.72% 4(th) 212/215 99(th)
ACUMEN Portfolio 7 -11.19% 4(th) 214/215 100(th)
ACUMEN Portfolio 8 -13.51% 4(th) 157/159 99(th)
Average -10.12% 4(th) 100(th)
Source of data: FE Analytics
A claim against Titan has been intimated and is being progressed by
Tavistock's legal representatives.
The statement made to the press by Titan on 9 July 2024 appears to reflect
Titan's view of the dispute, following Tavistock's decision to terminate.
Tavistock strongly denies the suggestion of wrongful conduct and considers
that Titan's allegations are false and have been put forward as a retaliatory
step.
The matter is now subject to pre-action correspondence and Tavistock does not
propose to comment further at this stage.
For further information:
Tavistock Investments Plc
Oliver Cooke Tel: 01753 867000
Brian Raven
Allenby Capital Limited Tel: 020 3328 5656
(Nominated adviser and broker)
Corporate Finance:
Nick Naylor, Liz Kirchner, Daniel Dearden-Williams
Sales and Corporate Broking:
Tony Quirke
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END FURFLFIDDIIILIS